Kris Kowdley
Clinical Faculty · Washington State University College of Medicine
Credentials: · · · · · ·
History
Research
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Review · Journal of Hepatology · 2023 · 2,696 citations
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis
New England Journal of Medicine · 2010 · 2,636 citations
The Lancet · 2015 · 1,829 citations
48 papers
46 papers
38 papers
- KL
35 papers
33 papers
30 papers
29 papers
27 papers
Grants
- 2002–2027
Clinical Research Network in Nonalcoholic Steatohepatitis
National Institute of Diabetes and Digestive and Kidney Diseases · U01
Contact PI · $9M · Liver Institute Northwest Pllc
- 2011–2017
The Role of Iron in the Pathogenesis of NAFLD
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $2.5M · Swedish Medical Center, First Hill
- 2013–2017
Novel Prognostic microRNA Biomarkers for Primary Sclerosing Cholangitis
National Institute of Diabetes and Digestive and Kidney Diseases · R21
Contact PI · $516.5K · Swedish Medical Center, First Hill
- 2008–2015
Hepatitis Beta Research Network Clinical Center in Pacific Northwest/Alaska
National Institute of Diabetes and Digestive and Kidney Diseases · U01
PI · $2.9M · University of Washington
Clinical trials
- 2005–2010
Effect of Omega-3 PUFA Supplementation in NAFLD Patients
Principal investigator · Completed
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- 2005–2010
Iron Depletion Therapy for Type 2 DM and NAFLD
Principal investigator · Completed
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- 2003–2006
IdB 1016 Treatment for Hepatitis C Disease
Principal investigator · Completed · Phase 1, Phase 2
National Center for Complementary and Integrative Health (NCCIH)
- 2025–2028
Site PI · Recruiting · Phase 3
GlaxoSmithKline